Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2000

01-03-2000

Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice

Authors: Zsuzsanna Kahán, Zsuzsanna Kahán, József L. Varga, József L. Varga, Andrew V. Schally, Andrew V. Schally, Zoltán Rékási, Zoltán Rékási, Patricia Armatis, Ioulia Chatzistamou, Ioulia Chatzistamou, Tamás Czömpöly, Tamás Czömpöly, Gábor Halmos, Gábor Halmos

Published in: Breast Cancer Research and Treatment | Issue 1/2000

Login to get access
Metadata
Title
Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice
Authors
Zsuzsanna Kahán
Zsuzsanna Kahán
József L. Varga
József L. Varga
Andrew V. Schally
Andrew V. Schally
Zoltán Rékási
Zoltán Rékási
Patricia Armatis
Ioulia Chatzistamou
Ioulia Chatzistamou
Tamás Czömpöly
Tamás Czömpöly
Gábor Halmos
Gábor Halmos
Publication date
01-03-2000
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2000
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1006363230990

Other articles of this Issue 1/2000

Breast Cancer Research and Treatment 1/2000 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine